Johnson David Michael's Form 4 filing
Aura Biosciences, Inc.AURA · filed Jun 14, 2022
- Accession no.
- 0000899243-22-022456
- Filed
- Jun 14, 2022
- Trade date
- Jun 10-13, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions. Open-market purchases total $716.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Johnson David MichaelCIK 0001808098 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 10, 2022 | Common Stock | PPurchaseAcquired | +3,000 | $15.04 | +$45,120 | 3,000 | Indirect | |
| Jun 10, 2022 | Common Stock | PPurchaseAcquired | +3,000 | $15.04 | +$45,120 | 3,000 | Indirect | |
| Jun 10, 2022 | Common Stock | PPurchaseAcquired | +10,000 | $15.04 | +$150,400 | 10,000 | Direct | |
| Jun 13, 2022 | Common Stock | PPurchaseAcquired | +7,000 | $13.99 | +$97,930 | 10,000 | Indirect | |
| Jun 13, 2022 | Common Stock | PPurchaseAcquired | +7,000 | $13.99 | +$97,930 | 10,000 | Indirect | |
| Jun 13, 2022 | Common Stock | PPurchaseAcquired | +20,000 | $13.99 | +$279,800 | 30,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.